114 related articles for article (PubMed ID: 2907468)
1. Pharmacokinetics of the dimethylheptyl homolog of cannabidiol in dogs.
Samara E; Bialer M
Drug Metab Dispos; 1988; 16(6):875-9. PubMed ID: 2907468
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of cannabidiol in dogs.
Samara E; Bialer M; Mechoulam R
Drug Metab Dispos; 1988; 16(3):469-72. PubMed ID: 2900742
[TBL] [Abstract][Full Text] [Related]
3. Identification of metabolites of the 1",1"-dimethylheptyl analogue of cannabidiol in rat and dog in vivo.
Samara E; Bialer M; Bar-On H; Harvey DJ
Xenobiotica; 1990 May; 20(5):447-55. PubMed ID: 2349804
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
5. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and metabolism of 3'-azido-2',3'-dideoxy-5-methylcytidine in rhesus monkeys.
Boudinot FD; Schinazi RF; Doshi KJ; McClure HM; Chu CK
Drug Metab Dispos; 1993; 21(5):855-60. PubMed ID: 7902248
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of 1,3-di(4-imidazolino-2-methoxyphenoxy) propane.lactate (DMP.lactate), a new agent against opportunistic infections, in male beagle dogs.
Bekersky I; Puhl RJ; Hanson G; Mong S
Drug Metab Dispos; 1994; 22(2):233-6. PubMed ID: 8013279
[TBL] [Abstract][Full Text] [Related]
8. Disposition of remoxipride in different species. Species differences in metabolism.
Widman M; Nilsson LB; Bryske B; Lundström J
Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers.
Paudel KS; Hammell DC; Agu RU; Valiveti S; Stinchcomb AL
Drug Dev Ind Pharm; 2010 Sep; 36(9):1088-97. PubMed ID: 20545522
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
Grubb MF; Wong YN; Burcham DL; Saxton PL; Quon CY; Huang SM
Drug Metab Dispos; 1994; 22(5):709-12. PubMed ID: 7835221
[TBL] [Abstract][Full Text] [Related]
12. (+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity only.
Fride E; Feigin C; Ponde DE; Breuer A; Hanus L; Arshavsky N; Mechoulam R
Eur J Pharmacol; 2004 Dec; 506(2):179-88. PubMed ID: 15588739
[TBL] [Abstract][Full Text] [Related]
13. Disposition of salmeterol xinafoate in laboratory animals and humans.
Manchee GR; Barrow A; Kulkarni S; Palmer E; Oxford J; Colthup PV; Maconochie JG; Tarbit MH
Drug Metab Dispos; 1993; 21(6):1022-8. PubMed ID: 7905380
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol.
Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E
Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
[TBL] [Abstract][Full Text] [Related]
17. Meperidine pharmacokinetics following intravenous, peroral and buccal administration in beagle dogs.
Ritschel WA; Neub M; Denson DD
Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):811-5. PubMed ID: 3441166
[TBL] [Abstract][Full Text] [Related]
18. Bioavailabilty and pharmacokinetics of four active alkaloids of traditional Chinese medicine Yanhuanglian in rats following intravenous and oral administration.
Li HL; Zhang WD; Zhang C; Liu RH; Wang XW; Wang XL; Zhu JB; Chen CL
J Pharm Biomed Anal; 2006 Jun; 41(4):1342-6. PubMed ID: 16644173
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability and pharmacokinetic studies of eurycomanone from Eurycoma longifolia.
Low BS; Ng BH; Choy WP; Yuen KH; Chan KL
Planta Med; 2005 Sep; 71(9):803-7. PubMed ID: 16206032
[TBL] [Abstract][Full Text] [Related]
20. Absorption, distribution and excretion of [14C]E-4716 after single-dose administration in rats and dogs.
Serafini MT; Puig S; Pretel MJ; García A; Martínez L
Methods Find Exp Clin Pharmacol; 1997; 19(6):407-15. PubMed ID: 9385590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
